PerpEquities

Akeso, Inc. (AKESO) balance sheet

HKSE · Healthcare · Biotechnology · 4,082 employees · CEO Yu Xia

Price
HK$78.90 -3.19%
Market cap
HK$72.7B
Enterprise value
CN¥57.8B
Last report
Q2 '26 filed 2026-06-30
Next report
2027-03-31

At the end of Q2 '26 Akeso, Inc. (AKESO) held CN¥9.16B in cash and short-term investments against CN¥4.98B of debt incl. leases. Total assets CN¥16.2B, total liabilities CN¥7.86B, shareholders' equity CN¥8.48B.

Balance sheet

Balance sheetTrendQ4 '20Q2 '21Q4 '21Q2 '22Q4 '22Q2 '23Q4 '23Q2 '24Q4 '24Q2 '25Q4 '25Q2 '26
Assets
Cash & equivalentsCN¥3.18BCN¥3.8BCN¥3.23BCN¥2.6BCN¥2.35BCN¥4.62BCN¥4.04BCN¥2.49BCN¥6.89BCN¥7.14BCN¥8.83BCN¥8.69B
Short-term investmentsCN¥133MCN¥221MCN¥113KCN¥11.8MCN¥220MCN¥1.19BCN¥2.87MCN¥3.54MCN¥426MCN¥545MCN¥349MCN¥471M
ReceivablesCN¥0CN¥164MCN¥139MCN¥304MCN¥274MCN¥257MCN¥296MCN¥463MCN¥532MCN¥809MCN¥1.02BCN¥966M
InventoryCN¥72.6MCN¥141MCN¥241MCN¥353MCN¥384MCN¥310MCN¥392MCN¥500MCN¥707MCN¥847MCN¥932MCN¥1.1B
Other current assetsCN¥144MCN¥167MCN¥208MCN¥146MCN¥154MCN¥658MCN¥66.4MCN¥2.8BCN¥93.3MCN¥144MCN¥152MCN¥231M
Current assetsCN¥3.56BCN¥4.37BCN¥3.86BCN¥3.49BCN¥3.43BCN¥6.47BCN¥5.68BCN¥6.75BCN¥8.69BCN¥8.94BCN¥11.3BCN¥11.5B
Property, plant & equipment (net)CN¥1.01BCN¥1.4BCN¥2.02BCN¥2.34BCN¥2.72BCN¥2.6BCN¥2.86BCN¥3.32BCN¥3.55BCN¥3.78BCN¥4.2BCN¥4.35B
Long-term investmentsCN¥0CN¥0CN¥0CN¥0CN¥10MCN¥358MCN¥305MCN¥349MCN¥415MCN¥397MCN¥371MCN¥273M
Intangible assetsCN¥1.46MCN¥3.82MCN¥4.87MCN¥7.59MCN¥9.54MCN¥8.15MCN¥322MCN¥8.74MCN¥11.8MCN¥11.1MCN¥19.1MCN¥17.3M
Deferred tax assetsCN¥0CN¥0CN¥0CN¥0-CN¥10MCN¥0CN¥0CN¥0CN¥0CN¥0CN¥0CN¥0
Other non-current assetsCN¥0CN¥1CN¥1CN¥1CN¥11.2MCN¥279MCN¥14.2MCN¥35MCN¥86.6MCN¥162MCN¥134MCN¥119M
Non-current assetsCN¥1.01BCN¥1.4BCN¥2.02BCN¥2.35BCN¥2.74BCN¥3.25BCN¥3.5BCN¥3.71BCN¥4.06BCN¥4.35BCN¥4.73BCN¥4.76B
Total assetsCN¥4.57BCN¥5.77BCN¥5.88BCN¥5.84BCN¥6.17BCN¥9.72BCN¥9.18BCN¥10.5BCN¥12.8BCN¥13.3BCN¥16BCN¥16.2B
Liabilities
Accounts payableCN¥113MCN¥106MCN¥206MCN¥278MCN¥309MCN¥270MCN¥355MCN¥399MCN¥425MCN¥470MCN¥1.6BCN¥689M
Accrued expensesCN¥35MCN¥54.6MCN¥87.2MCN¥89.7MCN¥134MCN¥168MCN¥0CN¥256MCN¥0CN¥0CN¥0CN¥0
Short-term debtCN¥13.8MCN¥5.55MCN¥45.6MCN¥190MCN¥446MCN¥304MCN¥391MCN¥273MCN¥535MCN¥514MCN¥586MCN¥975M
Taxes payableCN¥1.33MCN¥1.35MCN¥1.27MCN¥1.28MCN¥1.27MCN¥1.27MCN¥43.1MCN¥0CN¥0CN¥0CN¥0CN¥0
Deferred revenueCN¥671KCN¥1.35MCN¥382KCN¥363KCN¥6.69MCN¥11.7MCN¥0CN¥0CN¥0CN¥0CN¥0CN¥0
Other current liabilitiesCN¥37.3MCN¥36.7MCN¥309MCN¥741MCN¥633MCN¥256MCN¥445MCN¥469MCN¥37.3MCN¥1.03BCN¥253KCN¥1.19B
Current liabilitiesCN¥202MCN¥254MCN¥802MCN¥1.31BCN¥1.53BCN¥1.01BCN¥1.2BCN¥1.41BCN¥1.69BCN¥2.02BCN¥2.2BCN¥2.86B
Long-term debtCN¥179MCN¥434MCN¥804MCN¥1.13BCN¥1.42BCN¥2.22BCN¥2.58BCN¥3.03BCN¥3.41BCN¥4.01BCN¥3.96BCN¥3.99B
Lease obligations (non-current)CN¥3.7MCN¥5.88MCN¥2.24MCN¥967KCN¥5.95MCN¥10.8MCN¥8.61MCN¥2.91MCN¥674KCN¥9.62MCN¥9MCN¥10.5M
Deferred revenue (non-current)CN¥53.4MCN¥42.3MCN¥63.9MCN¥77.3MCN¥160MCN¥682MCN¥872MCN¥875MCN¥908MCN¥891MCN¥896MCN¥931M
Deferred tax liabilitiesCN¥130MCN¥399MCN¥743MCN¥1.05BCN¥1.27BCN¥2.23BCN¥174KCN¥174KCN¥174KCN¥162KCN¥150KCN¥70K
Other non-current liabilities-CN¥19.6MCN¥46.5MCN¥116MCN¥117MCN¥15.6MCN¥62.7MCN¥0CN¥876MCN¥0CN¥892MCN¥0CN¥64.1M
Non-current liabilitiesCN¥216MCN¥529MCN¥986MCN¥1.32BCN¥1.6BCN¥3.09BCN¥3.46BCN¥3.91BCN¥4.31BCN¥4.91BCN¥4.86BCN¥4.99B
Total liabilitiesCN¥418MCN¥782MCN¥1.79BCN¥2.63BCN¥3.13BCN¥4.1BCN¥4.66BCN¥5.32BCN¥6BCN¥6.93BCN¥7.06BCN¥7.86B
Equity
Common stock & paid-in capitalCN¥65.2KCN¥68.5KCN¥69.7KCN¥66.8KCN¥66.2KCN¥63.7KCN¥59KCN¥61KCN¥63KCN¥63KCN¥65KCN¥65K
Retained earnings-CN¥1.99B-CN¥2.52B-CN¥3.36B-CN¥3.96B-CN¥4.4B-CN¥1.5B-CN¥1.89B-CN¥2.13B-CN¥2.4B-CN¥2.97B-CN¥3.47BCN¥0
Accumulated other comprehensive incomeCN¥2.64BCN¥2.83BCN¥2.4BCN¥2.42BCN¥2.3BCN¥2.23BCN¥2BCN¥1.71BCN¥1.81BCN¥6.44BCN¥1.98BCN¥8.49B
Shareholders' equityCN¥3.78BCN¥4.64BCN¥3.87BCN¥3.06BCN¥2.96BCN¥5.58BCN¥4.69BCN¥5.23BCN¥6.81BCN¥6.44BCN¥9.05BCN¥8.48B
Debt
Total debt (incl. leases)CN¥236MCN¥545MCN¥1.05BCN¥1.55BCN¥2.11BCN¥2.74BCN¥2.99BCN¥3.32BCN¥3.95BCN¥4.54BCN¥4.56BCN¥4.98B
Net debt (debt - cash)-CN¥2.95B-CN¥3.26B-CN¥2.18B-CN¥1.05B-CN¥239M-CN¥1.88B-CN¥1.05BCN¥831M-CN¥2.94B-CN¥2.6B-CN¥4.27B-CN¥3.7B

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in CNY.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-02 · Amounts in CNY as reported; price and market cap in HKD.